Clinical Trial Update: IVIG Versus Placebo for the Treatment of Patients With Severe C-Diff [Phase 4]

View source ↗

Summary

Phase 4 trial evaluating intravenous immunoglobulin (IVIG) versus placebo for severe Clostridioides difficile infection was terminated; results were posted in 2…

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Clostridioides Difficile Infection

Drugs mentioned

• IVIG (intravenous immunoglobulin)

Snippet

Sponsor: University of Pittsburgh | Conditions: Clostridium Difficile-associated Diarrhea (CDAD) | Phase 4 | Status: TERMINATED | Results posted: 2016-07-15